Trial record 1 of 1 for:    CLEE011A2404
Previous Study | Return to List | Next Study

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02941926
Recruitment Status : Recruiting
First Posted : October 21, 2016
Last Update Posted : January 17, 2018
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 30, 2019
  Estimated Study Completion Date : November 30, 2019